Stocks surge after Pfizer and BioNTech vaccines granted 'fast-track' status—Three experts on what's next

Stocks rose after Pfizer and BioNTech vaccines received 'fast-track' status, indicating Covid-19 optimism. Here's what strategists and portfolio managers say is next for the second half of the year and how investors should be prepared.
02:49
Mon, Jul 13 202011:51 AM EDT
RELATED VIDEOS
02:49
Stocks surge after Pfizer and BioNTech vaccines granted 'fast-track' status—Three experts on what's next
03:10
Trading Nation: Two traders on whether Nikola or Nio can be a viable Tesla competitior
04:37
Pinterest tops social media stocks this year, but traders see a different long-term winner
04:00
One chipmaker is the best bet on future tech growth, long-time tech investor Paul Meeks says
02:32
Trading Nation: Here are the top stock performers of July
04:55
Gold hits all-time highs, but miners lag. What two traders make of the moves
05:51
Stocks rise after Big Tech crushes earnings—Five experts on what the numbers mean